Page last updated: 2024-09-04

docetaxel anhydrous and Hypersensitivity

docetaxel anhydrous has been researched along with Hypersensitivity in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Banerji, A; Blumenthal, KG; Cogan, AS; McMahon, AE; Robinson, LB; Saff, RR; Wolfson, AR1
Ichikawa, G; Nakanishi, K; Okazaki, S; Suzuki, S1
Chen, L; Guo, X; Liu, H; Liu, J; Shi, Y; Tang, C; Zhao, Y; Zheng, X1
Chen, KR; Hayakawa, N; Honda, A; Ito, Y; Kosaka, T; Maeda, T; Nagata, H; Nakamura, S; Okata, U; Oya, M1
Anderson, CM; Barrett, B; Dorr, VJ; Lyss, AP; Malhotra, V; Perry, MC; Reynolds, M; Westgate, S1

Reviews

1 review(s) available for docetaxel anhydrous and Hypersensitivity

ArticleYear
Polysorbate 80 as a possible allergenic component in cross-allergy to docetaxel and fosaprepitant: A literature review.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2023, Volume: 29, Issue:8

    Topics: Allergens; Docetaxel; Dyspnea; Humans; Hypersensitivity; Polysorbates

2023

Trials

1 trial(s) available for docetaxel anhydrous and Hypersensitivity

ArticleYear
Neoadjuvant and adjuvant chemotherapy with doxorubicin and docetaxel in locally advanced breast cancer.
    Clinical breast cancer, 2004, Volume: 5, Issue:5

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Breast Neoplasms; Combined Modality Therapy; Docetaxel; Doxorubicin; Female; Follow-Up Studies; Heart; Humans; Hypersensitivity; Kidney; Liver; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Nerve Tissue; Neutropenia; Radiography; Taxoids; Treatment Outcome

2004

Other Studies

3 other study(ies) available for docetaxel anhydrous and Hypersensitivity

ArticleYear
COVID-19 vaccines tolerated in patients with paclitaxel and docetaxel allergy.
    Allergy, 2022, Volume: 77, Issue:3

    Topics: COVID-19; COVID-19 Vaccines; Docetaxel; Humans; Hypersensitivity; Paclitaxel; SARS-CoV-2

2022
Allergy testing for Cremophor in a patient with cervical cancer with infusion reactions to paclitaxel and docetaxel.
    BMJ case reports, 2022, Jun-24, Volume: 15, Issue:6

    Topics: Docetaxel; Female; Humans; Hypersensitivity; Paclitaxel; Polyethylene Glycols; Taxoids; Uterine Cervical Neoplasms

2022
Evaluation of histopathological findings at the injection site following degarelix administration.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015, Volume: 23, Issue:5

    Topics: Aged; Aged, 80 and over; Docetaxel; Drug Therapy, Combination; Erythema; Gonadotropin-Releasing Hormone; Hematologic Diseases; Humans; Hypersensitivity; Injections, Subcutaneous; Male; Middle Aged; Oligopeptides; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Risk Factors; Skin; Taxoids

2015